Research progress on metabolic bone disease of prematurity

doi:10.11852/zgetbjzz2018-26-09-14

Abstract

Abstract: Metabolic bone disease (MBD) of prematurity is defined as disorder of diminished bone mineralization,leading to bone changes, decrease of bone trabecular and cortex of bone. There are no typical clinical symptoms or sensitive and specific examination indicators in the early stage of the disease. While serious complications have occurred in later diagnosis, such as rickets or pathological fracture. So it is important to discover,diagnose and treat early. This paper focuses on the publications in recent years to summarize the background,influencing factors,clinical manifestation,diagnosis,treatment and prevention measures of MBD.

Key words: premature, metabolic bone disease, diagnosis, treatment, prevention

摘要： 早产儿代谢性骨病,是指由于体内钙磷代谢紊乱所致的骨矿物质含量的异常,导致骨小梁数量减少、骨皮质变薄等骨骼改变。该病早期缺乏典型的临床症状或者敏感且特异的检查指标,后期确诊已出现严重并发症,如出现佝偻病或病理性骨折。所以早期发现、明确诊断和有效治疗亟待解决。本文主要就有关早产儿代谢性骨病的临床表现、诊断、治疗及预防措施进行综述。

关键词: 早产儿, 代谢性骨病, 诊断, 治疗, 预防

CLC Number:

R179

SONG Ying-dong,WANG Li-ping, XU Ding, LI Yan-ping, JIANG Chun-qian, SUN Ni. Research progress on metabolic bone disease of prematurity[J]. journal1, 2018, 26(9): 981-984.

宋迎冬,王利平,徐丁,李艳萍,姜春倩,孙妮. 早产儿代谢性骨病研究进展[J]. 中国儿童保健杂志, 2018, 26(9): 981-984.

0
/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/10.11852/zgetbjzz2018-26-09-14

https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/Y2018/V26/I9/981

References

[1] Nallagonda S, Nallagonda M, Deorukhkar A. Metabolic bone disease of prematurity - an overview[J]. Paed Child Healt-can 2017, 27(1):14-17.
[2] Jonathan P,Alastair R,Charles G,et al.Metabolic bone disease[J].J Orthop Trauma,2017,31(5):306-311.
[3] Chhina AS, Shenoi A, Nagendra N, et al. Vitamin D and metabolic bone parameters in preterm neonates[J]. Indian Pediatr, 2016,53(11):1023.
[4] Figuerasaloy J, ÁlvarezDomínguez E, Pérezfernández JM, et al. Metabolic bone disease and bone mineral density in very preterm infants[J]. J Pediatr,2014,164(3):499-504.
[5] Harrison CM, Johnson K, Mckechnie E. Osteopenia of prematurity: a national survey and review of practice[J]. Acta Paediatr, 2008, 97(4):407-413.
[6] Rustico SE, Calabria AC, Garber SJ. Metabolic bone disease of prematurity[J].J Clin Endocr Metab,2014,1(3):85-91.
[7] Gaio P, Verlato G,Daverro M, et al.Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia[J].Clin Nutr ESPEN,2017,23:234-239.
[8] 张荣娜,修文龙.早产儿代谢性骨病[J].实用儿科临床杂志,2011,26(8):624-627.
[9] 欧丽黎,李吉华.骨碱性磷酸酶、血25-羟维生素D₃联合骨密度对小儿维生素D缺乏性佝偻病的诊断价值[J].医学综述,2018,24(7):1449-1452.
[10] 赵春生,裴春红.成年男性碱性磷酸酶活力降低的主要临床意义[J].中国医学创新,2011,8(12):104-105.
[11] 庄兴,陈福祥.成纤维母细胞生长因子23的研究进展[J].国际检验医学杂志,2011,32(7):778-781.
[12] 朱万胜,吴道全.fgf-23与慢性肾脏病的研究进展[J].西部医学,2017,29(4):588-592.
[13] 袭艳梅,侯洪涛.成纤维细胞生长因子23在早产儿代谢性骨病的意义[J].实用医学杂志,2018,34(2):235-238.
[14] Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional Rickets[J]. Horm Res Paediat, 2016, 85(2):83-106.
[15] Moreira A, Swischuk L, Malloy M, et al. Parathyroid hormone as a marker for metabolic bone disease of prematurity[J]. J Perinatol, 2014, 34(10):787-791.
[16] Rustico SE, Kelly A, Monk HM, et al. Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: a preliminary study[J]. J Clin Endocr Metab, 2015, 2(1):14-20.
[17] 李源斌,陆妹.早产儿血清25羟基维生素D₃水平与超声骨密度的相关性研究[J].中国当代医药,2017,4(13):106-108.
[18] 郭晓红.骨钙素检测的发展及其临床应用[J].中国卫生检验杂志,2017,27(18):2731-2733.
[19] 阙文君,冯正平.骨转换生化标志物的研究进展[J].中国骨质疏松杂志,2014,20(5):575-579.
[20] Bartell SM,Rayalam S, Ambati S, et al. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression ofosteogenic genes in leptin deficientob/ob mice[J]. J Bone Miner Res, 2011,26(8):1710-1720.
[21] Berry PA, Jones SW, Cicuttini FM, et al. Temporal relationship between serumAdipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with cinical kee oteoarthritis[J].Arthritis Rheum-us, 2011, 63(3):700-707.
[22] 王峰,郑陆.脂联素、瘦素与运动及骨代谢的关系[J].中国骨质疏松杂志,2016,22(2):221-227.
[23] Reid P, Holen I. Pathophysiological roles of osteoprotegerin (OPG)[J]. Eur J Cell Biol, 2009, 88(1):1.
[24] Kostenuik PJ, Nguyen HQ, Mccabe J, et al. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in Knock-in mice that express chimeric (murine/human) RANKL[J]. J Bone Miner Res, 2009,24(2):182-195.
[25] Visser F, Sprij AJ, Brus F. The validity of biochemical markers in metabolic bone disease in preterm infants: a systematic review[J]. Acta Paediatr, 2012,101(6):562-568.
[26] 张乐嘉,丁国芳.早产儿代谢性骨病[J].中国实用儿科杂志,2015,30(2):100-104.
[27] Rack B, Lochmüller EM, Janni W, et al. Ultrasound for the assessment of bone quality in preterm and term infants[J]. J Perinatol, 2012, 32(3):218-226.
[28] 孔令凯,孔祥永.早产儿代谢性骨病[J].中国医刊,2014,49(3):21-23.
[29] Mcdevitt H, Tomlinson C, White MP, et al. Changes in quantitative ultrasound in infants born at less than 32 weeks' gestation over the first 2 years of life: influence of clinical and biochemical changes[J]. Calcified Tissue Int, 2007, 81(4):263-269.
[30] 王丹虹,陈平洋.早产儿代谢性骨病防治进展[J].国际儿科学杂志,2014,41(5):508-510.
[31] Bozzetti V,Tagliabue P.Metabolic Bone disease in pretermn newborn:an update on nutritional issues[J]. Ital J Pediatr,2009,35(1):20.
[32] Abrams SA. In utero physiology: role in nutrient delivery and fetal development for calcium, phosphorus, and vitamin D[J]. Am J Clin Nutr, 2007, 85(2):604S.
[33] 韩露艳,王丹华.早产儿代谢性骨病[J].中国新生儿科杂志,2010,25(4):253-254.
[34] Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition[J]. J Pediatr Gastr Nutr, 2010,50(1):85-91.
[35] Hovi P,Andersson S,Jarvenpaa AL,et al. Decreased bone mineral density in adults born with very low birth weight:a cohortstudy[J].PloS Med,2009,6(8):e1000135.
[36] Schulzke SM, Kaempfen S, Trachsel D,et al.Physical activity programs for promoting bone mineralization and growth in preterm infants[J].Cochrane Database Syst Rev,2014,4:CD005387.